Norvaline

Norvaline

SCHEMBL15570207

CCCCO.CCC[C@H](N)C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 5/20 0.57
SLC1A2 P43004 4/20 0.57
SLC1A1 P43005 4/20 0.57
GRIK2 Q13002 4/20 0.57
SLC1A3 P43003 3/20 0.57
GSR P00390 2/20 0.52
DDAH1 O94760 3/20 0.49
CHRM1 P11229 1/20 0.48
AKR1A1 P14550 1/20 0.48
CHRM3 P20309 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
ADRA1A P35348 1/20 0.48
HRH1 P35367 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
NOS1 P29475 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norvaline SCHEMBL15570206 1.00 GRIK1 (0.57) GRIK1SLC1A2SLC1A1GRIK2SLC1A3
Norleucine SCHEMBL1053852 0.87 SLC1A2 (0.62) GRIK1SLC1A2SLC1A1GRIK2SLC1A3
Norleucine SCHEMBL1053849 0.87 SLC1A2 (0.62) GRIK1SLC1A2SLC1A1GRIK2SLC1A3
Norvaline SCHEMBL38405 0.87
Norvaline SCHEMBL840389 0.87 SLC1A2 (0.64) GRIK1SLC1A2SLC1A1GRIK2SLC1A3
Norvaline SCHEMBL17449755 0.87
Norvaline SCHEMBL38404 0.87
Norvaline SCHEMBL197812 0.87
Norvaline SCHEMBL21114359 0.87 SLC1A2 (0.64) GRIK1SLC1A2SLC1A1GRIK2SLC1A3
Norvaline SCHEMBL542602 0.87 SLC1A2 (0.64) GRIK1SLC1A2SLC1A1GRIK2SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885415-A1 TWO STAGE PRODUCTION OF HIGHER ALCOHOLS Easel Biotechnologies LLC (US) 2015-06-24 EP disclosed
WO-2014028642-A1 TWO STAGE PRODUCTION OF HIGHER ALCOHOLS EASEL BIOTECHNOLOGIES, LLC (US) 2014-02-20 WO disclosed